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SUMMARY. Rhizoma Paridis saponins (RPS) were considered to be the principal bioactive components of
Paris polyphylla Smith var. yunnanensis. Intestinal microflora-mediated metabolism may affect their phar-
macological activities in vivo. In this study, the biotransformation of RPS by rat intestinal microflora in
vitro was investigated. A high-performance liquid chromatography with electrospray ionization combined
with mass spectrometry (HPLC-ESI-MS) method was developed to identify RPS and their metabolites.
The metabolism of RPS by rat intestinal microflora was mainly based on cleavage of the oligosaccharide
chains which is connected to the C-3 or C-22 position. However, the elimination of the glucose molecule at
C-26 and F-ring closure occurred firstly in prototype saponins. In addition, the biotransformation routes
of RPS in the presence of rat intestinal microflora were elaborated, from which RPS were presumed pri-
marily responsible for the metabolism via α-rhamnosidase and β-glycosidase activities. These results
would contribute to understanding of the mechanisms in bioavailability of herbal drugs and their metabo-
lites.
